Jenni M.

Jenni M. is an experienced professional in the field of statistics with a focus on clinical development and infectious diseases. Currently serving as Director at Moderna since November 2022, Jenni oversees projects related to infectious diseases, including RSV and hMPV/RSV combination treatments. Previously, Jenni held the position of Associate Director at Regeneron, contributing to a phase 3 Covid program, and at Ultragenyx Pharmaceutical Inc., leading gene therapy clinical development. Other roles include Principal Statistician at Sage Therapeutics, focused on CNS disease clinical development, and Senior Statistician at Biogen, working on multiple sclerosis late phase development. Jenni began a career in statistics at Eli Lilly and Company, where work included diabetes and autoimmune phase 3 studies. Jenni earned a Ph.D. in Statistics from the University of California, Davis, and a Master of Arts in Statistics from UC Santa Barbara.